For the Significance of the Study, Pseudomonas aeruginosa infection is already known

to have increasing prevalence worldwide, and in the Philippines, a growing number of

cases are noted in both hospital and community. Since Ceftazidime is the first-line
agents for treating Pseudomonas infections, there is high likelihood that antibiotic
resistance would eventually develop.
This study will benefit the following:
1st the Academe/Researchers: This study will serve as their future reference for
studies related to the determination of the antimicrobial effectiveness and activity of
honey.
2nd would be the Healthcare workers: This study would help them in providing an
alternative treatment for bacterial infections and in realizing the potential of honey as an
aid in decreasing the morbidity and mortality outcomes of Pseudomonas aeruginosa.
And lastly would be the Patient: It will provide them an alternative therapy that is cost
effective adjunct to traditional antibiotics which can help impede antibiotic resistance.

SCOPE AND LIMITATION

The study aims to investigate the effectiveness of in-vitro antimicrobial activity of

Philippine honey, Ceftazidime, and Philippine honey together with Ceftazidime with
different concentrations, namely as 20%, 40%, 60%, 80% and 100%, in inhibiting
Pseudomonas aeruginosa. The study will only be limited to the organism,
Pseudomonas aeruginosa, which will be obtained at Ospital ng Muntinlupa & the
experiments will be performed at Emilio Aguinaldo College - Manila, School of Medical
Technology Laboratory.